home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Products Used in Early Phase IND Studies

 
  November 23, 2017  
     
 
Netzealous LLC DBA - Compliance4All, Online
2018-01-19


Overview:
How it may be integrated with the recommendations of the guidance 

documents on CMC requirements.

Areas Covered in the Session:
Discussion of the elements found in the guidance document for Phase 1 

material
What to do at really early stages
What about special IND studies?
What about preclinical studies?

Who Will Benefit:
Regulatory Affairs personnel who coordinate activities for the CMC 

sections of submissions
QA/QC personnel who need to plan work on early stage material
R & D personnel who will contribute data to CMC sections
Project managers for product development studies
Quality systems auditors
Consultants


Event Fee: One Dial-in One Attendee Price: US$150.00

Contact Detail:
Compliance4All DBA NetZealous,
Phone: +1-800-447-9407
Email: support@compliance4All.com
 
 
Organized by: Event Manager
Invited Speakers:
Speaker Profile:
Steven S. Kuwahara , Ph.D. is the founder and Principal of GXP 

BioTechnology LLC, a consulting firm that works in the areas covered 

by the GLP and GMP of drugs, biologics, and nutraceuticals. Steve has 

over 30 years of experience in supervising quality control laboratories, 

including an animal testing facility, and in performing GLP and GMP 

audits of internal and external testing laboratories .
 
Deadline for Abstracts: 2018-01-18
 
Registration: http://www.compliance4all.com/control/w_product/~product_id=501658LIVE?channel=molgen_Jan_2018_SEO
E-mail: support@compliance4All.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.